4
Changes in Ownership
Lexeo Therapeutics, Inc. Filed Acc 0001209191-23-054910
Chief Technical Officer acquired 3,191 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
McCormac Paul · Chief Technical Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-11-07 | Conversion : show line 1 in the form | +3,191 | 17,349 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-11-07 | Conversion : show line 2 in the form Series B convertible preferred stock | −29,061 | 0 | D |
Loading xslF345X05/doc4.xml…